Takeda, MacroGenics End Autoimmune Drug Pact
By
Takeda Pharmaceutical Company has ended its license and option agreement for an anti-cancer drug candidate with MacroGenics, a Rockville, Maryland-based clinical-stage biopharmaceutical company focused on monoclonal antibody-based cancer therapeutics. MacroGenics…